The role of glutamate neurotransmission in mismatch negativity (MMN), a measure of auditory synaptic plasticity and change-detection

Publication date: Available online 8 February 2020Source: NeuroscienceAuthor(s): Lauren Harms, Gloria G. Parras, Patricia T. Michie, Manuel S. MalmiercaAbstractMismatch Negativity (MMN) is an electrophysiological signature that occurs in response to unexpected stimuli. It is often referred to as a measure of memory-based change detection, because the elicitation of a prediction error response relies on the formation of a prediction, which in turn, is dependent upon intact memory of previous auditory stimulation. As such, the MMN is altered in conditions in which memory is affected, such as Alzheimer’s disease, schizophrenia and healthy aging. The most prominent pharmacological finding for MMN strengthens the link between MMN and synaptic plasticity, as glutamate N-methyl-D-aspartate receptor (NMDA-R) antagonists reduce the MMN response. However, recent data has begun to demonstrate that the link between NMDA-R function and MMN is not as clear as once thought, with low dose and low affinity NMDA-R antagonists observed to facilitate MMN.

Source: Neuroscience - February 9, 2020 Category: Neuroscience Source Type: research